Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Weight loss intervention fails in endometrial cancer survivors

Publish date:: April 7, 2020

Key clinical point: Obese survivors of endometrial cancer did not benefit from a weight loss intervention.

Major finding: Weight gain occurred similarly over 12 months in endometrial cancer survivors treated with a weight loss intervention (49%) and in those who declined the intervention (47%).

Study details: A retrospective study of 358 obese endometrial cancer survivors.

Disclosures: Dr. Zamorano reported having no disclosures. The research was funded by Washington University.

Citation:

Zamorano A et al. SGO 2020, Abstract 20.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Gynecologic Cancer

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

Is diagnostic hysteroscopy safe in patients with type 2 endometrial cancer?,

Cervical cancer recurrence patterns differ after laparoscopic and open hysterectomy,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Half of women treated for gynecologic cancers miss or skip doses of oral drugs,